Meghna Rao

Researchers sought to assess the relationship between hospital closures and level of area socioeconomic disadvantage and racial/ethnic minority composition.

Researchers assessed the association between age at menopause, vascular risk, and prospective cognition.

Researchers sought to assess the impact of education attainment on functional performance in Black patients with AD pathology, and whether this effect varies between carriers and noncarriers of the APOE ε4 allele.

Researchers sought to determine the cognitive performance of patients with both low and high glucose levels, as well as identify the characteristics predictive of differences in cognitive vulnerability to changing glucose levels.

In a longitudinal analysis, researchers evaluated how high-efficacy therapies impact transitions across 5 disability states in patients with pediatric-onset multiple sclerosis.

A study was conducted to determine the effect of anxiety or depression treatments on clinical outcomes following hospitalization for ischemic disorders and heart failure.

In a prospective observational study, researchers compared the 8 most commonly used ASM monotherapies during pregnancy with regard to risk for MCMs in offspring of women with epilepsy.

A study was conducted to determine the relationship between protruding aortic plaque and coronary plaque characteristics.

A study was conducted to determine predictors of referral to community-based rehabilitation during discharge following acute stroke.

Researchers sought to assess the gaps in acute treatment optimization of migraine among participants from the CaMEO-I study.

In a retrospective analysis, researchers evaluated the effect of DMT discontinuation on risk for disease activity in MS.

In a post-hoc analysis, researchers determined the safety and efficacy of fremanezumab in patients with migraine and obesity.

In a phase 3, double-blind, multi-center, randomized-controlled trial, researchers evaluated the safety and efficacy of AXS-05 in AD-related agitation.

In a post-hoc analysis of a phase 3 trial, researchers determined the effect of RNA interference therapeutic vutrisiran on hATTR amyloidosis with polyneuropathy.

Researchers explored the impacts of bariatric surgery-induced weight loss on cognition, as well as brain structure and perfusion.

In a phase 4 randomized clinical trial, researchers compared the safety and efficacy of erenumab and nonspecific oral migraine preventive medications in patients with resistant episodic migraine.

In a cross-sectional study, researchers determined the positivity rate of phosphorylated α-synuclein deposition via skin biopsy in patients with Parkinson disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.

Researchers sought to assess whether PTSD is associated with the risk for rehospitalization after stroke and whether racial disparities exist.

A study was conducted to compare telemedicine hypertension management with usual clinic-based care for blood pressure control.

In a cross-sectional analysis, researchers assessed rates of ischemic and hemorrhagic stroke in the US from 1990 to 2019.

In a systematic review, researchers assessed the effect of initial CIVAD on outcome measures in refractory status epilepticus.

The use of assisted reproductive technology (ART) is associated with an increased risk for stroke during delivery hospitalization.

Researchers sought to assess the performance of ChatGPT 3.5 and 4.0 regarding pediatric cardiology knowledge.

In a discussion panel, a pediatric neurologist, a psychiatrist, and a clinical neuropsychologist share their insights on screening for and diagnosing autism.

In an ad hoc interim analysis presented at ACTRIMS Forum 2024, researchers described changes in reported outcomes by patients with relapsing MS after 1 year on ozanimod.

In a study presented at ACTRIMS Forum 2024, researchers reported on the latest cumulative pregnancy outcomes data in women with relapsing MS on ofatumumab during or in the 6 months prior to pregnancy.

In a study presented at ACTRIMS Forum 2024, researchers reported whether patients with RMS who received ofatumumab 20 mg every 4 weeks could mount a humoral immune response to the 2020-2021, 2021-2022, or 2022-2023 inactivated influenza vaccine.

In a study presented at ACTRIMS Forum 2024, researchers compared the risk for severe infections between patients with MS treated with diroximel fumarate vs anti-CD20s.

Researchers sought to assess whether gut microbiome composition is associated with schizophrenia diagnosis, treatment resistance, clozapine response, and adverse effects.

In a population-based cohort study, researchers evaluated the effect of PDE5I use compared with nonuse and the risk for Alzheimer disease among men with erectile dysfunction.